LifeStance Health (LFST) Net Cash Flow (2020 - 2026)

LifeStance Health (LFST) has 7 years of Net Cash Flow data on file, last reported at -$53.8 million in Q1 2026.

• Quarterly Net Cash Flow fell 166.1% year-over-year to -$53.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.5 million (down 28.77% YoY) and the FY2025 annual result came in at $94.1 million, up 24.19% from the prior year.
• Net Cash Flow retreated to -$53.8 million in Q1 2026 per LFST's latest filing, from $44.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $54.6 million in Q2 2025 and bottomed at -$53.8 million in Q1 2026.
• The 5-year median for Net Cash Flow is $11.3 million (2023), against an average of $2.8 million.
• The widest annual swing landed in 2023, when Net Cash Flow sank 482.68%; it then surged 231.69% in 2024.
• Tracing LFST's Net Cash Flow over 5 years: stood at $18.3 million in 2022, then surged by 98.08% to $36.2 million in 2023, then soared by 43.45% to $52.0 million in 2024, then slipped by 13.89% to $44.7 million in 2025, then plunged by 220.35% to -$53.8 million in 2026.
• Per Business Quant, the three latest LFST Net Cash Flow figures stand at -$53.8 million (Q1 2026), $44.7 million (Q4 2025), and $15.0 million (Q3 2025).

Peer Comparison